Back to Search
Start Over
Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model.
- Source :
-
Chinese medical journal [Chin Med J (Engl)] 2023 Jan 05; Vol. 136 (1), pp. 102-104. Date of Electronic Publication: 2023 Jan 05. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 2542-5641
- Volume :
- 136
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Chinese medical journal
- Publication Type :
- Academic Journal
- Accession number :
- 36723862
- Full Text :
- https://doi.org/10.1097/CM9.0000000000002520